Azulfidine Interactions
There are 264 drugs known to interact with Azulfidine (sulfasalazine), along with 12 disease interactions. Of the total drug interactions, 46 are major, 209 are moderate, and 9 are minor.
- View all 264 medications that may interact with Azulfidine
- View Azulfidine disease interactions (12)
Most frequently checked interactions
View interaction reports for Azulfidine (sulfasalazine) and the medicines listed below.
- aspirin
- atorvastatin
- Celebrex (celecoxib)
- Cymbalta (duloxetine)
- doxycycline
- duloxetine
- Flexeril (cyclobenzaprine)
- folic acid
- gabapentin
- Humira (adalimumab)
- hydrochlorothiazide
- Klonopin (clonazepam)
- levothyroxine
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- lisinopril
- losartan
- metformin
- methotrexate
- Nexium (esomeprazole)
- omeprazole
- pantoprazole
- Plaquenil (hydroxychloroquine)
- prednisone
- Prilosec (omeprazole)
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Azulfidine disease interactions
There are 12 disease interactions with Azulfidine (sulfasalazine) which include:
- colitis
- intestinal obstruction
- urinary obstruction
- hematologic toxicity
- hypersensitivity reactions
- liver disease
- porphyria
- renal dysfunction
- renal dysfunction
- folate deficiency
- G6PD deficiency
- crystalluria
Report options
QR code containing a link to this page
More about Azulfidine (sulfasalazine)
- Azulfidine consumer information
- Compare alternatives
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: 5-aminosalicylates
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
